American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 28, Issue 1 , Pages 3-8 , January 2007

Concurrent chemoradiation for locally advanced oropharyngeal cancer

  • Nam P. Nguyen, MD

      Affiliations

    • Department of Radiation Oncology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA
    • Radiation Oncology, VA North Texas Health Care System, Dallas, TX, USA
    • Corresponding Author InformationCorresponding author. Radiation Oncology Service (111), VA North Texas Health Care System, Dallas, TX 75216, USA. Tel.: +1 214 857 0142; fax: +1 214 857 0145.
    • ,
  • Paul Vos, PhD

      Affiliations

    • Department of Biostatistics, East Carolina University, Greenville, NC, USA
    • ,
  • Herbert J. Smith, MD

      Affiliations

    • Radiology, VA North Texas Health Care System, Dallas, TX, USA
    • ,
  • Phuc D. Nguyen, MD

      Affiliations

    • Department of Radiation Oncology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA
    • Radiation Oncology, VA North Texas Health Care System, Dallas, TX, USA
    • ,
  • Alan Alfieri, PhD

      Affiliations

    • Department of Radiation Oncology, Albert Einstein College of Medicine, New York, NY, USA
    • ,
  • Ulf Karlsson, MD, PhD

      Affiliations

    • Department of Radiation Oncology, East Carolina University, Greenville, NC, USA
    • ,
  • Suresh Dutta, MD

      Affiliations

    • Department of Radiation Oncology, University of Southern California, Los Angeles, CA, USA
    • ,
  • Claire Lemanski, MD

      Affiliations

    • Department of Radiation Oncology, Centre Val D'Aurelle, Montpellier, France
    • ,
  • Ly M. Nguyen, BS

      Affiliations

    • School of Public Health, University of Michigan, Ann Arbor, MI, USA
    • ,
  • Sabah Sallah, MD

      Affiliations

    • Novo Nordisk, Division of Hematology/Oncology Research, Athens, Greece

References 

  1. Lauciello FR, Vergo T, Schaff NG, et al. Prosthodontic and speech rehabilitation after partial and complete glossectomy. J Prosthet Dent. 1980;43:204–211
  2. Pauloski BR, Rademaker AW, Logemann JA, et al. Pretreatment swallowing function in patients with head and neck cancer. Head Neck. 2000;22:472–482
  3. Tupchong L, Scott CB, Blitzer PH, et al. Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: long-term follow-up of RTOG study 73-03. Int J Radiat Oncol Biol Phys. 1991;20:21–28
  4. Pauloski BR, Logemannn JA, Colangelo LA, et al. Surgical variables affecting speech in treated patients with oral and oropharyngeal cancer. Laryngoscope. 1998;108:908–916
  5. Pauloski BR, Logemann JA. Impact of tongue base and posterior pharyngeal wall biomechanics on pharyngeal clearance in irradiated postsurgical oral and oropharyngeal cancer patients. Head Neck. 2000;22:120–131
  6. Nguyen NP, Sallah S. Combined chemotherapy and radiation in the treatment of locally advanced head and neck cancers. In Vivo. 2000;14:35–39
  7. Nguyen NP, Sallah S, Karlsson U, et al. Combined chemotherapy and radiation therapy for head and neck malignancies. Cancer. 2002;94:1131–1141
  8. Pauloski BR, Rademaker AW, Logemann JA, et al. Surgical variables affecting swallowing in patients treated for oral/oropharyngeal cancer. Head Neck. 2004;26:625–636
  9. Dropkin MJ. Body image and quality of life after head and neck cancer surgery. Cancer Pract. 1999;7:309–313
  10. Denitis AS, Machtay M, Rosenthal DI, et al. Advanced oropharyngeal carcinoma treated with surgery and radiotherapy: oncologic outcome and functional assessment. Am J Otolaryngol. 2001;22:329–335
  11. Lawrence TS, Blackstock AW, McGinn C. The mechanism of action of radiosensitization of conventional chemotherapeutic agents. Semin Radiat Oncol. 2003;13:13–21
  12. Calais G, Alfonsi M, Bardet E, et al. Randomized trial of radiation therapy versus concurrent chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst. 1999;91:2081–2086
  13. Olmi P, Crispino S, Fallai C, et al. Locoregionally advanced carcinoma of the oropharynx: conventional radiotherapy vs. accelerated hyperfractionated radiotherapy vs. concomitant radiotherapy and chemotherapy—a multicenter randomized trial. Int J Radiat Oncol Biol Phys. 2003;55:78–92
  14. Machtay M, Rosenthal DI, Hershock D, et al. Organ preservation therapy using induction plus concurrent chemoradiation for advanced resectable oropharyngeal carcinoma: a University of Pennsylvania Phase II trial. J Clin Oncol. 2002;20:3964–3971
  15. Nguyen NP, Moltz CC, Frank C, et al. Severity and duration of chronic dysphagia following treatment for head and neck cancer. Anticancer Res. 2005;25:2929–2934
  16. Nguyen NP, Frank C, Moltz CC, et al. Impact of dysphagia on quality of life after treatment of head and neck cancer. Int J Radiat Oncol Biol Phys. 2005;61:772–778
  17. Adelstein DJ, Adams GL, Wagner H, et al. An Intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiation in patients with unresectable squamous head and neck cancer. J Clin Oncol. 2003;21:92–98
  18. Eisbruch A, Lyden T, Bradford CR, et al. Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2002;53:23–28
  19. Pauloski BR, Rademaker AW, Logemann JA, et al. Swallow function and perception of dysphagia in patients with head and neck cancer. Head Neck. 2002;24:555–565
  20. Martin-Harris B, Logemann JA, McMahon S, et al. Clinical utility of the modified barium swallow. Dysphagia. 2000;15:136–141
  21. Kotz T, Abraham S, Beitler JJ, et al. Pharyngeal dysfunction consequent to an organ sparing protocol. Arch Otolaryngol Head Neck Surg. 1999;125:480–483
  22. Maguire MD, Peyerson MB, Neal CR, et al. Toxic cure: hyperfractionated radiotherapy with concurrent cisplatin and fluorouracil for stage III and IVA head and neck cancer in the community. Int J Radiat Oncol Biol Phys. 2004;58:598–704
  23. Kotz T, Abraham S, Beitler JJ, et al. Pharyngeal dysfunction consequent to an organ sparing protocol. Arch Otolaryngol Head Neck Surg. 1999;125:480–483
  24. Nguyen NP, Antoine JE, Dutta S, et al. Current concept in radiation enteritis and implications for future clinical trials. Cancer. 2002;95:1153–1163
  25. Heldin CH, Miyazono K, ten Didjke P. TGF-β signaling from cell membrane to nucleus through SMADS proteins. Nature. 1997;390:465–471
  26. Buntzel J, Glatzel M, Kuttner K, et al. Amifostine in simultaneous radio-chemotherapy of advanced head and neck cancer. Semin Radiat Oncol. 2002;12:4–13

PII: S0196-0709(06)00056-1

doi: 10.1016/j.amjoto.2006.03.007

American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 28, Issue 1 , Pages 3-8 , January 2007

Article Tools

* Image Usage & Resolution